Another dual-targeted approach was developed to treat glioma with DOX, combining a magnetic targeting Fe3O4 and molecular brain targeting using transferrin, whose receptor is overexpressed on glioma cells and on the vascular endothelial cells of the BBB [189]. This evidence concerns the gene TF and glioma.